In a large randomized trial, atorvastatin 40 mg daily significantly reduced major cardiovascular events by 30% among community-dwelling adults aged…
In patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM), aficamten significantly improved exercise capacity and patient-reported health status compared with placebo…
In patients with atrial fibrillation at intermediate risk for stroke, direct oral anticoagulant (DOAC) therapy significantly reduced the 24-month risk…
The recombinant shingles vaccine was associated with a 9% reduction in overall cardiovascular burden over 7 years among adults aged…
In community-dwelling older adults without prior cardiovascular disease (CVD), new or persistent heart stress (HS)—defined by elevated NT-proBNP concentrations over…
In adults aged 75 years or older without a history of atherosclerotic cardiovascular disease (ASCVD) who were taking statins for…
A Chinese nationwide study of 273,921 patients hospitalized with heart failure (HF) found a U-shaped association between left ventricular end-diastolic…
A systematic review and meta-analysis found that intravenous thrombolysis (IVT) given 4.5 hours or more after acute ischemic stroke onset…
Waist circumference (WC) and waist-to-hip ratio (WHR) identified important differences in cardiovascular disease (CVD) risk that were not captured by…
Maintaining optimal vascular health in midlife was associated with up to 12.6 additional years of life free from dementia between…
This website uses cookies.